High expression of octamer transcription factor 1 in cervical cancer

Oncology Letters

Volumn 7, Issue 6, 2014, Pages 1889-1894

  Xiao, Songshu ^a   Liao, Shan ^b   Zhou, Yanhong ^b   Jiang, Bin ^a   Li, Yueran ^a   Xue, Min ^a  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cervical cancer; Gene expression; Octamer transcription factor 1

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HERMES ANTIGEN; MICRORNA; OCTAMER TRANSCRIPTION FACTOR 1;

ADULT; ARTICLE; CANCER INCIDENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; MIDDLE AGED; MOLECULAR PATHOLOGY; MRNA EXPRESSION ASSAY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; TUMOR BIOPSY; TUMOR GROWTH; UTERINE CERVIX CANCER; WESTERN BLOTTING;

EID: 84898871339     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2023     Document Type: Article

References (27)

1. Sharma C, Nusri Qel-A, Begum S, et al: (-)-Epigallocatechin-3-gallate induces apoptosis and inhibits invasion and migration of human cervical cancer cells. Asian Pac J Cancer Prev 13: 4815-4822, 2012.
2. Wobus M, Kuns R, Wolf C, Horn LC, Köhler U, Sheyn I, Werness BA and Sherman LS: CD44 mediates constitutive type I receptor signaling in cervical carcinoma cells. Gynecol Oncol 83: 227-234, 2001.
3. Wu JH, Liang XA, Wu YM, Li FS and Dai YM: Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay. Oncol Rep 29:125-132, 2013.
4. Wu SF, Qian WY, Zhang JW, Yang YB, Liu Y, Dong Y, Zhang ZB, Zhu YP and Feng YJ: Network motifs in the transcriptional regulation network of cervical carcinoma cells respond to EGF. Arch Gynecol Obstet 287: 771-777, 2013.
5. Saavedra KP, Brebi PM and Roa JC: Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix. Clin Epigenetics 4: 13, 2012.
6. Wang J, Wang Q, Liu H, Shao N, Tan B, Zhang G, Wang K, Jia Y, Ma W, Wang N and Cheng Y: The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies. Mutagenesis 27: 779-788, 2012.
7. Maddox J, Shakya A, South S, Shelton D, Andersen JN, Chidester S, Kang J, Gligorich KM, Jones DA, Spangrude GJ, Welm BE and Tantin D: Transcription factor Oct1 is a somatic and cancer stem cell determinant. PLoS Genet 8: e1003048, 2012.
8. Lin R, Li X, Li J, Zhang L, Xu F, Chu Y and Li J: Long-term cisplatin exposure promotes methylation of the OCT1 gene in human esophageal cancer cells. Dig Dis Sci 58: 694-698, 2013.
9. Sturm RA, Cassady JL, Das G, Romo A and Evans GA: Chromosomal structure and expression of the human OTF1 locus encoding the Oct-1 protein. Genomics 16: 333-341, 1993.
10. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001.
11. Y Wang, W Zheng, D Peng, S Xiong, W Ma, J Zeng, Z Wu, M Zhou, M Xiang, J Xiang, B Li, X Li, X and Li G: Risk of nasopharyngeal carcinoma associated with polymorphic lactotransferrin haplotypes. Med Oncol 29: 1456-1462, 2012.
12. Ruan L, Wang GL, Chen Y, Yi H, Tang CE, Zhang PF, Li MY, Li C, Peng F, Li JL, Chen ZC and Xiao ZQ: Identification of tyrosine phosphoproteins in signaling pathway triggered TGF-a by using functional proteomics technology. Med Oncol 27: 1407-1414, 2010.
13. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Muñoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19, 1999.
14. Mariani L and Venuti A: HPV vaccine: an overview of immune respose, clinical protections, and new approaches for the future. J Trans Med 8: 105, 2010.
15. Peralta-Zaragoza O, Bermúdez-Morales VH, Pérez-Plasencia C, Salazar-León J, Gómez-Cerón C and Madrid-Marina V: Targeted treatments for cervical cancer: a review. Onco Targets Ther 5: 315-328, 2012.
16. Zhu Y, Zheng Y, Mei L, Liu M, Li S, Xiao H, Zhu H, Wu S, Chen H and Huang L: Enhanced immunotherapeutic effect of modified HPV16 E7-pulsed dendritic cell vaccine by an adeno-shRNA-SOCS1 virus. Int J Oncol 43: 1151-1159, 2013.
17. Bonito NA, Drechsler J, Stoecker S, Carmo CR, Seckl MJ, Hermanns HM and Costa-Pereira AP: Control of gp130 expression by the mitogen-activated protein kinase ERK2. Oncogene: May 20, 2013 (Epub ahead of print).
18. Kim YW, Bae SM, Kim YW, Park DC, Lee KH, Liu HB, Kim IW, Jang CK and Ahn WS: Target-based molecular signature characteristics of cervical adenocarcinoma and squamous cell carcinoma. Int J Oncol 43: 539-547, 2013.
19. Norman I, Hjerpe A and Andersson S: High-risk HPV L1 capsid protein as a marker of cervical intraepithelial neoplasia in high-risk HPV-positive women with minor cytological abnormalities. Oncol Rep 30: 695-700, 2013.
20. Yuan Y, Zhang J, Cai L, et al: Leptin induces cell proliferation and reduces cell apoptosis by activating c-myc in cervical cancer. Oncol Rep 29: 2291-2296, 2013.
21. Porameesanaporn Y, Uthaisang-Tanechpongtamb W, Jarintanan F, Jongrungruangchok S and Thanomsub Wongsatayanon B: Terrein induces apoptosis in HeLa human cervical carcinoma cells through p53 and ERK regulation. Oncol Rep 29: 1600-1608, 2013.
22. Gupta S, Wulf G, Henjakovic M, Koepsell H, Burckhardt G and Hagos Y: Human organic cation transporter 1 is expressed in lymphoma cells and increases susceptibility to irinotecan and paclitaxel. J Pharmacol Exp Ther 341: 16-23, 2012.
23. Hwang-Verslues WW, Chang PH, Jeng YM, Kuo WH, Chiang PH, Chang YC, Hsieh TH, Su FY, Lin LC, Abbondante S, Yang CY, Hsu HM, Yu JC, Chang KJ, Shew JY, Lee EY and Lee WH: Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancy. Proc Natl Acad Sci USA 110: 12331-12336, 2013.
24. Obinata D, Takayama K, Urano T, Murata T, Kumagai J, Fujimura T, Ikeda K, Horie-Inoue K, Homma Y, Ouchi Y, Takahashi S and Inoue S: Oct1 regulates cell growth of LNCaP cells and is a prognostic factor for prostate cancer. Int J Cancer 130: 1021-1028, 2012.
25. Kang J, Shakya A and Tantin D: Stem cells, stress, metabolism and cancer: a drama in two Octs. Trends Biochem Sci 34: 491-499, 2009.
26. Jariwala U, Cogan JP, Jia L, Frenkel B and Coetzee GA: Inhibition of AR-mediated transcription by binding of Oct1 to a motif enriched in AR-occupied regions. Prostate 69: 392-400, 2009.
27. Shakya A, Kang J, Chumley J, Williams MA and Tantin D: Oct1 is a switchable, bipotential stabilizer of repressed and inducible transcriptional states. J Biol Chem 286: 450-459, 2011.